Trial site
Miami Cancer Institute at Baptist Health, Inc.
- 14running trials
- 7closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers3 trials
- Lung cancer3 trials
- Multiple myeloma3 trials
- Brain metastases2 trials
- Metastatic breast cancer2 trials
- Triple-negative breast cancer2 trials
- Acute lymphoblastic leukaemia1 trial
- Acute myeloid leukaemia1 trial
- Bladder cancer1 trial
- Cervical cancer1 trial
- Chronic lymphocytic leukaemia1 trial
- Chronic myeloid leukaemia1 trial
- and 8 more
- Phase
- Phase 28 trials
- Phase 36 trials
- Phase 1/23 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Recruiting11 trials
- Terminated5 trials
- Active, not recruiting3 trials
- Completed1 trial
- Suspended1 trial
- Withdrawn1 trial
- Lead sponsor
- Baptist Health South Florida7 trials
- Pfizer3 trials
- Eli Lilly and Company2 trials
- Seagen Inc.2 trials
- Allogene Therapeutics1 trial
- and 7 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
Recruiting
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Recruiting
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Recruiting
Recruiting
Recruiting
Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer
Active, not recruiting
Recruiting
Cabozantinib for Patients With Recurrent or Progressive Meningioma
Active, not recruiting
Recruiting
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Multiple myeloma2 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Glioblastoma1 recruiting
- Meningioma1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Terminated
Withdrawn
CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies
Terminated
Terminated
Terminated
Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma
Completed
Terminated
Site data: ClinicalTrials.govUpdated 19 Nov 2026